Wolters Kluwer Health to be Exclusive Provider of New England Journal of Medicine Site Licenses in China; Companies Expand Global Distribution Agreement
Ovid to be Exclusive Site License Partner for Current and Archival NEJM Content in China
Source Newsroom: Wolters Kluwer Health - Ovid
Newswise — New York, NY (January 20, 2014) -–Wolters Kluwer Health today announced it has extended its global distribution agreement with the New England Journal of Medicine (NEJM.org), the leading publisher of breakthrough biomedical research and best practices in clinical medicine, to be the exclusive provider of NEJM site licenses in China. Under terms of the new agreement, Ovid, part of Wolters Kluwer Health, will be the exclusive provider of NEJM site licenses in China providing access to unembargoed content on either Ovid or NEJM.org platforms as well as access to the NEJM archive on NEJM.org.
“China is an important growth market for NEJM and Wolters Kluwer Health brings extensive experience in this market to help us build our NEJM brand,” said Chris Lynch, VP for Publishing of NEJM Group. “The OvidSP research solution offers NEJM additional global reach, allowing us to bring important medical research and clinical content to even more healthcare professionals and researchers than ever before.”
“China is a fast growing market for medical research and our long standing presence and field sales force in this region offers tremendous advantage for partners like New England Journal of Medicine,” said Andrew Richardson, Vice President, Business Development, Wolters Kluwer Health, Medical Research. “We’re delighted to extend this partnership to bring highly valued content from NEJM to practitioners and students in China and around the world.”
In addition, Ovid will continue to provide access to current, non-embargoed NEJM content to institutions globally. Ovid customers will have site-wide access to current issues of the New England Journal of Medicine back to through 1990 in PDF format, plus links to NEJM’s Online First articles.
Ovid is a global information solutions provider offering clinicians, researchers, and students in the medical, scientific, and academic fields customizable solutions of trusted, evidence-based content, and tools and services that make research smarter, faster, and more effective. Ovid’s research platform is used by more than 12,500 institutions worldwide.
The New England Journal of Medicine (NEJM.org), the world’s leading medical journal and website, is a publication of NEJM Group, a division of the Massachusetts Medical Society. Founded in 1812, NEJM publishes peer-reviewed research and interactive clinical content for physicians, educators and the global medical community.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.